216 related articles for article (PubMed ID: 7970481)
21. Reliability of magnetic resonance imaging in assessing myometrial invasion absence in endometrial carcinoma.
Suh DS; Kim JK; Kim KR; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Acta Obstet Gynecol Scand; 2009; 88(9):990-3. PubMed ID: 19636979
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative gross assessment of myometrial invasion and cervical involvement in endometrial cancer: Role of tumor grade and size.
Fotiou S; Vlahos N; Kondi-Pafiti A; Zarganis P; Papakonstantinou K; Creatsas G
Gynecol Oncol; 2009 Mar; 112(3):517-20. PubMed ID: 19117598
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of MR imaging for the prediction of myometrial invasion of endometrial carcinoma.
Chung HH; Kang SB; Cho JY; Kim JW; Park NH; Song YS; Kim SH; Lee HP
Gynecol Oncol; 2007 Mar; 104(3):654-9. PubMed ID: 17095081
[TBL] [Abstract][Full Text] [Related]
24. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
[TBL] [Abstract][Full Text] [Related]
25. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
26. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
[TBL] [Abstract][Full Text] [Related]
27. Endometrial endometrioid adenocarcinoma: a pathologic analysis of 827 consecutive cases.
Nofech-Mozes S; Ghorab Z; Ismiil N; Ackerman I; Thomas G; Barbera L; Covens A; Khalifa MA
Am J Clin Pathol; 2008 Jan; 129(1):110-4. PubMed ID: 18089496
[TBL] [Abstract][Full Text] [Related]
28. Clinical stage I and II endometrial carcinoma: multivariate analysis of prognostic factors.
Mammoliti S; Bruzzone M; Chiara S; Vidali A; Miglio L; Fontana V; Oliva C; Compora E; Giuntini P; Centonze M
Anticancer Res; 1992; 12(5):1415-8. PubMed ID: 1444199
[TBL] [Abstract][Full Text] [Related]
29. [Value of MRI in the assessment of invasion depth by endometrial carcinoma].
Wang LX; Ouyang H; Wu LY; Lian SD; Wang S; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):373-6. PubMed ID: 17045005
[TBL] [Abstract][Full Text] [Related]
30. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].
Backe J; Gassel AM; Müller T; Schön S; Kaesemann H
Zentralbl Gynakol; 1997; 119(7):334-42. PubMed ID: 9340973
[TBL] [Abstract][Full Text] [Related]
31. Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases.
Rechichi G; Galimberti S; Signorelli M; Franzesi CT; Perego P; Valsecchi MG; Sironi S
AJR Am J Roentgenol; 2011 Jul; 197(1):256-62. PubMed ID: 21701038
[TBL] [Abstract][Full Text] [Related]
32. Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer?
Lindauer J; Fowler JM; Manolitsas TP; Copeland LJ; Eaton LA; Ramirez NC; Cohn DE
Gynecol Oncol; 2003 Dec; 91(3):547-51. PubMed ID: 14675674
[TBL] [Abstract][Full Text] [Related]
33. Is endometrial carcinoma intrinsically more aggressive in elderly patients?
Alektiar KM; Venkatraman E; Abu-Rustum N; Barakat RR
Cancer; 2003 Dec; 98(11):2368-77. PubMed ID: 14635071
[TBL] [Abstract][Full Text] [Related]
34. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
35. Predictors of final histology in patients with endometrial cancer.
Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
[TBL] [Abstract][Full Text] [Related]
37. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma.
Stokes GN; Shelton JB; Zahn CM; Kendall BS
Gynecol Oncol; 2002 Jan; 84(1):58-61. PubMed ID: 11748977
[TBL] [Abstract][Full Text] [Related]
38. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer.
Gadducci A; Cavazzana A; Cosio S; DI Cristofano C; Tana R; Fanucchi A; Teti G; Cristofani R; Genazzani AR
Anticancer Res; 2009 May; 29(5):1715-20. PubMed ID: 19443392
[TBL] [Abstract][Full Text] [Related]
39. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%.
Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Massuger LF
Gynecol Oncol; 2013 May; 129(2):285-91. PubMed ID: 23422503
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.
Stefansson IM; Salvesen HB; Immervoll H; Akslen LA
Histopathology; 2004 May; 44(5):472-9. PubMed ID: 15139995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
